```

[Federal Register Volume 88, Number 206 (Thursday, October 26, 2023)]
[Notices]
[Page 73604]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-23628]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health

National Institute on Drug Abuse; Notice of Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the National Advisory 
Council on Drug Abuse.
    The meeting will be held as a virtual meeting and is open to the 
public, as indicated below. Individuals who plan to view the virtual 
meeting and need special assistance such as sign language 
interpretation or other reasonable accommodations to view the meeting, 
should notify Dr. Jeanette Marketon via email at 
[email protected] five days in advance of the meeting. The open 
session will be videocast and can be accessed from the NIH Videocasting 
and Podcasting website (http://videocast.nih.gov/).
    A portion of the meeting will be closed to the public in accordance 
with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), 
Title 5 U.S.C., as amended. The intramural programs and projects as 
well as the grant applications and/or contract proposals and the 
discussions could disclose confidential trade secrets or commercial 
property such as patentable material, and personal information 
concerning individuals associated with intramural programs and projects 
as well as the grant applications and/or contract proposals, the 
disclosure of which would constitute a clearly unwarranted invasion of 
personal privacy.

    Name of Committee: National Advisory Council on Drug Abuse.
    Date: February 6, 2024.
    Closed: 10:30 a.m. to 11:45 a.m. Agenda: To review and evaluate 
grant applications.
    Closed: 11:45 a.m. to 12:15 p.m. Agenda: Report to Council from 
the NIDA Board of Scientific Counselors (BSC).
    Open: 12:45 p.m. to 5:00 p.m. Agenda: Presentations and other 
business of the Council.
    Place: National Institutes of Health, National Institute on Drug 
Abuse, 301 North Stonestreet Avenue, Bethesda, MD 20892 (Virtual 
Meeting).
    Contact Person: Susan R.B. Weiss, Ph.D., Director, Division of 
Extramural Research, Office of the Director, National Institute on 
Drug Abuse, NIH, Three White Flint North, RM 09D08, 11601 Landsdown 
Street, Bethesda, MD 20852 301-443-6480 [email protected].
    Contact Person: Jeanette Marketon, Ph.D., Director, Office of 
Extramural Policy, Division of Extramural Research Office of 
Extramural Policy, National Institute on Drug Abuse, NIH, Three 
White Flint North, RM 09C68, 11601 Landsdown Street, Bethesda, MD 
20852, 301-443-5239 [email protected].

    Any interested person may file written comments with the 
committee by forwarding the statement to Dr. Jeanette Marketon at 
[email protected]. The statement should include the name, 
address, telephone number and when applicable, the business or 
professional affiliation of the interested person.
    Information is also available on the Institute's/Center's home 
page: www.drugabuse.gov/NACDA/NACDAHome.html, where an agenda and 
any additional information for the meeting will be posted when 
available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug 
Abuse Scientist Development Award for Clinicians, Scientist 
Development Awards, and Research Scientist Awards; 93.278, Drug 
Abuse National Research Service Awards for Research Training; 
93.279, Drug Abuse and Addiction Research Programs, National 
Institutes of Health, HHS)

    Dated: October 20, 2023.
David W. Freeman,
Supervisory Program Analyst, Office of Federal Advisory Committee 
Policy.
[FR Doc. 2023-23628 Filed 10-25-23; 8:45 am]
BILLING CODE 4140-01-P
```